home / stock / anab / anab short
Short Information | AnaptysBio Inc. (NASDAQ:ANAB)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 1,026,954 |
Total Actual Volume | 8,508,243 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 51,348 |
Average Short Percentage | 13.10% |
Is there a ANAB Short Squeeze or Breakout about to happen?
See the ANAB Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
05-06-2024 | $26.6 | $25.77 | $26.63 | $25.29 | 195,199 | 35,357 | 18.11% |
05-03-2024 | $26.76 | $26.58 | $27.02 | $25.64 | 332,065 | 25,871 | 7.79% |
05-02-2024 | $26.26 | $26.34 | $26.74 | $24.75 | 324,822 | 52,316 | 16.11% |
05-01-2024 | $24.38 | $26.02 | $26.35 | $24.38 | 794,807 | 113,306 | 14.26% |
04-30-2024 | $21.26 | $24.34 | $24.5 | $21.02 | 1,100,993 | 116,163 | 10.55% |
04-29-2024 | $21.02 | $21.3 | $22.74 | $21.02 | 719,618 | 39,108 | 5.43% |
04-26-2024 | $18.92 | $21 | $21.61 | $18.715 | 649,412 | 72,382 | 11.15% |
04-25-2024 | $18.87 | $18.87 | $19.3 | $18.49 | 401,012 | 42,875 | 10.69% |
04-24-2024 | $19.01 | $19.27 | $19.29 | $18.71 | 308,207 | 35,814 | 11.62% |
04-23-2024 | $19.52 | $19.18 | $20.48 | $19.17 | 387,321 | 40,408 | 10.43% |
04-22-2024 | $19.93 | $19.66 | $20.265 | $19.6 | 139,714 | 28,324 | 20.27% |
04-19-2024 | $19.61 | $19.87 | $20.66 | $19.08 | 288,943 | 49,964 | 17.29% |
04-18-2024 | $21.29 | $19.83 | $21.78 | $19.785 | 363,855 | 65,082 | 17.89% |
04-17-2024 | $21.27 | $21.47 | $21.56 | $20.83 | 297,067 | 42,105 | 14.17% |
04-16-2024 | $21.55 | $21.34 | $22.15 | $21.03 | 244,875 | 33,766 | 13.79% |
04-15-2024 | $22.56 | $21.27 | $23.1 | $21.06 | 267,275 | 38,188 | 14.29% |
04-12-2024 | $24.89 | $22.71 | $24.94 | $22.53 | 347,661 | 64,203 | 18.47% |
04-11-2024 | $24.81 | $24.73 | $25.62 | $23.86 | 572,975 | 55,991 | 9.77% |
04-10-2024 | $21.08 | $22.17 | $22.45 | $20.71 | 349,285 | 38,942 | 11.15% |
04-09-2024 | $20.61 | $21.53 | $21.82 | $20.38 | 423,137 | 36,789 | 8.69% |
News, Short Squeeze, Breakout and More Instantly...
Actym Therapeutics Appoints Thomas Smart as CEO PR Newswire BERKELEY, Calif. , April 24, 2024 /PRNewswire/ -- Actym Therapeutics , pioneering a new drug modality to treat solid tumors, announced today the appointment of Thomas Smart as Chief Executive Off...
2024-04-16 09:00:05 ET David Risinger from Leerink Partners issued a price target of $47.00 for ANAB on 2024-04-16 07:27:00. The adjusted price target was set to $47.00. At the time of the announcement, ANAB was trading at $21.27. The overall price target consensus is at...
2024-04-12 19:00:50 ET Many stocks were wobbly over the past few trading days, but we can't say that about biotech AnaptysBio (NASDAQ: ANAB) . The company's shares closed the week almost 8% higher in price, according to data compiled by S&P Global Market Intelligence , large...